DS
Dr. Sachin N. Sanap
Cipla (India), Sun Pharmaceutical Industries Limited, Vadodara, Central Drug Research Institute
0000-0002-1427-9247
Employment
-
Cipla (India) Formulation Scientist2026 - Present
-
Sun Pharmaceutical Industries Limited, Vadodara Formulation Scientist2023 - 2026
-
Central Drug Research Institute Senior Research Fellow2019 - 2022
Education
-
Central Drug Research Institute PhD2019 - 2022
Projects & Funding
Projects & funding information is unavailable.
Publications (12)
- Targeted Pharmacokinetics and LC–MS/MS Analysis of Novel Anti‐Dyslipidemic Phytochemical Biomarkers From Polyalthia longifolia Enriched Fraction (4655‐EF) Save
- Ointment for Topical Ocular Delivery of Voriconazole: Formulation Development, In‐Vitro Characterization & In‐Vivo Pharmacokinetic Assessment Save
- Corneal Targeted Mucoadhesive Emulsion for Prolonged Delivery of Voriconazole: Formulation Evaluation and Pharmacokinetic Assessment Save
- Reversed‐Phase Analytical Method for Enantioselective Analysis of Ormeloxifene Hydrochloride: Application to Bulk Drug and Quality Control Analysis Save
- Application of lyophilization in pharmaceutical injectable formulations: An industry and regulatory perspective Save
- A review on polymers in ocular drug delivery systems Save
- Codetermination of antimicrobial agents in rabbit tear fluid using LC–MS/MS assay: Insights into ocular pharmacokinetic study Save
- USFDA-approved parenteral peptide formulations and excipients: Industrial perspective Save
- Pirfenidone: A Promising Drug in Ocular Therapeutics Save
- Hesperidin: Enrichment, forced degradation, and structural elucidation of potential degradation products using spectral techniques Save